{"nctId":"NCT00948818","briefTitle":"Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation","startDateStruct":{"date":"2009-07"},"conditions":["Irritable Bowel Syndrome Characterized by Constipation"],"count":803,"armGroups":[{"label":"Linaclotide","type":"EXPERIMENTAL","interventionNames":["Drug: Linaclotide 290 micrograms"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Matching placebo"]}],"interventions":[{"name":"Linaclotide 290 micrograms","otherNames":[]},{"name":"Matching placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient meets protocol criteria for IBS: reports abdominal discomfort or pain that has two or more of the following three features:\n\n  1. Relieved with defecation\n  2. Onset associated with a change in frequency of stool\n  3. Onset associated with a change in form (appearance) of stool\n* Patient reports \\< 3 bowel movements (BMs) per week (in the absence of any laxative, suppository, or enema use during the preceding 24 hours) and reports straining, lumpy or hard stools, and/or sensation of incomplete evacuation during \\> 25% of BMs\n* Patient has successfully completed protocol procedures (with no clinically significant findings): physical exam, 12-lead ECG, or clinical laboratory tests (some patients may require a colonoscopy per American Gastroenterological Association (AGA) guidelines)\n* Patient is compliant with Interactive Voice Response System (IVRS) for daily diary reporting of BM habits and IBS symptoms\n\nExclusion Criteria:\n\n* Patient has history of loose or watery stools for \\>25% of BMs\n* Patient has a structural abnormality of the gastrointestinal (GI) tract or a history of a disease or condition that can affect GI motility\n* Patient has any protocol-excluded or clinically significant medical or surgical history or concomitant medication use that could confound the study assessments","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 9 Out of 12 Weeks","description":"A patient is considered to be an APC responder if, for at least 9 out of the 12 weeks of the treatment period, the patient had at least 3 CSBMs, experienced an increase of at least 1 CSBM from baseline, and experienced a decrease of at least 30 percent in their Abdominal Pain (AP) score from baseline during a particular week.\n\nThe AP score assesses the worst of a patient's AP in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no AP and 10 represents very severe AP.\n\nA CSBM is defined as a spontaneous bowel movement, associated with a sense of complete evacuation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"49","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"375","spread":null},{"groupId":"OG001","value":"356","spread":null}]}]}]},{"type":"SECONDARY","title":"12-Week Complete Spontaneous Bowel Movement (CSBM) Frequency Rate","description":"The number of CSBMs per week.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.705","spread":"0.128"},{"groupId":"OG001","value":"2.272","spread":"0.127"}]}]}]},{"type":"PRIMARY","title":"Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder, 9 Out of 12 Weeks","description":"A patient is considered to be a CSBM 3+1 responder if, for at least 9 out of the 12 weeks of the treatment period, the patient had at least 3 CSBMs and experienced an increase of at least 1 CSBM from baseline during a particular week.\n\nA CSBM was defined as a Spontaneous Bowel Movement (SBM) that was associated with a sense of complete evacuation.\n\nAn SBM was defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"370","spread":null},{"groupId":"OG001","value":"326","spread":null}]}]}]},{"type":"PRIMARY","title":"Abdominal Pain Responder, 9 Out of 12 Weeks","description":"A patient is considered to be an abdominal pain responder if, for at least 9 out of the 12 weeks of the treatment period, they experienced a decrease of at least 30 percent in the mean abdominal pain score from baseline during a particular week.\n\nThe Abdominal Pain score assesses the worst of a patient's abdominal pain in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no abdominal pain and 10 represents very severe abdominal pain.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"107","spread":null},{"groupId":"OG001","value":"139","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"288","spread":null},{"groupId":"OG001","value":"266","spread":null}]}]}]},{"type":"PRIMARY","title":"Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 6 Out of 12 Weeks.","description":"A patient is considered an APC responder if, for at least 6 of the 12 weeks of the treatment, the patient experienced an increase of at least 1 Complete Spontaneous Bowel Movement (CSBM) from baseline and experienced a decrease of at least 30 percent in their Abdominal Pain (AP)score during a particular week.\n\nThe AP score assesses the worst of a patient's AP in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no AP and 10 represents very severe AP.\n\nA CSBM was defined as a Spontaneous Bowel Movement (SBM) that was associated with a sense of complete evacuation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"136","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"312","spread":null},{"groupId":"OG001","value":"269","spread":null}]}]}]},{"type":"SECONDARY","title":"12-Week Spontaneous Bowl Movement (SBM) Frequency Rate","description":"The number of Spontaneous Bowl Movements experienced per week.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.130","spread":".0177"},{"groupId":"OG001","value":"3.898","spread":"0.176"}]}]}]},{"type":"SECONDARY","title":"12-Week Stool Consistency","description":"The consistency of each BM was assessed by patients using the 7-point Bristol Stool Form Scale (BSFS) from 1 to 7.\n\n1. = separate hard lumps like nuts \\[difficult to pass\\]\n2. = sausage shaped but lumpy\n3. = like a sausage but with cracks on surface\n4. = like a sausage or snake, smooth and soft\n5. = soft blobs with clear-cut edges \\[passed easily\\]\n6. = fluffy pieces with ragged edges, a mushy stool\n7. = watery, no solid pieces \\[entirely liquid\\]).","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.662","spread":"0.061"},{"groupId":"OG001","value":"2.071","spread":"0.060"}]}]}]},{"type":"SECONDARY","title":"12-Week Severity of Straining","description":"Straining is measured on a 5-point scale where a value of 1 is \"not at all\" and a value of 5 is \"an extreme amount.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.651","spread":"0.042"},{"groupId":"OG001","value":"-1.306","spread":"0.042"}]}]}]},{"type":"SECONDARY","title":"12-Week Change in Abdominal Pain Score","description":"Abdominal Pain at its worst (in the last 24 hours) is based on an 11-point scale where 0 represents no abdominal pain and 10 represents very severe abdominal pain.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.129","spread":"0.094"},{"groupId":"OG001","value":"-1.869","spread":"0.093"}]}]}]},{"type":"SECONDARY","title":"12-Week Change in Abdominal Discomfort","description":"Abdominal Discomfort is measured on an 11-point scale where a value of 0 is \"none\" and a value of 10 is \"very severe.\"","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.211","spread":"0.097"},{"groupId":"OG001","value":"-1.953","spread":"0.096"}]}]}]},{"type":"SECONDARY","title":"12-Week Change in Bloating","description":"Bloating was assessed on an 11-point scale where a value of 0 is \"none\" and a value of 10 is \"very severe\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.100","spread":"0.100"},{"groupId":"OG001","value":"-1.944","spread":"0.099"}]}]}]},{"type":"SECONDARY","title":"Complete Spontaneous Bowl Movement (CSBM) Responder for 6 Weeks Out of 12 Weeks of Treatment","description":"A patient is considered to be a CSBM responder if, for at least 6 out of the 12 weeks of the treatment period, an increase of at least 1 CSBM per week from baseline was experienced.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"117","spread":null},{"groupId":"OG001","value":"197","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"278","spread":null},{"groupId":"OG001","value":"208","spread":null}]}]}]},{"type":"SECONDARY","title":"Abdominal Pain Responder for 6 Out of 12 Weeks","description":"A patient is considered to be an abdominal pain responder if, for at least 6 out of the 12 weeks of the treatment period, they experienced a decrease of 30 percent or more in the abdominal pain score from baseline.\n\nThe Abdominal Pain score assesses the worst of a patient's abdominal pain in the past 24 hours using an 11-point scale (from 0-10), where 0 represents no abdominal pain and 10 represents very severe abdominal pain.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"148","spread":null},{"groupId":"OG001","value":"203","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"247","spread":null},{"groupId":"OG001","value":"202","spread":null}]}]}]},{"type":"SECONDARY","title":"12-Week Percent of Abdominal Pain-free (APF) Days","description":"Abdominal pain free (APF) days are those days where the patient reported a score of '0' for abdominal pain at its worst\n\nAbdominal Pain at its worst (in the last 24 hours) is based on an 11-point scale where 0 represents no abdominal pain and 10 represents very severe abdominal pain.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.31","spread":"15.74"},{"groupId":"OG001","value":"9.81","spread":"21.75"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":396},"commonTop":["Diarrhea","Abdominal pain"]}}}